JPRN-UMIN000011678招募中未知
To Compare the renoprotective effect of sitagliptin and vildagliptin for patient with type 2 diabetic nephropathy - To Compare the renoprotective effect of sitagliptin and vildagliptin for patient with type 2 diabetic nephropathy
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who has contraindication with sitagliptin Patients who has contraindication with vildagliptin Patients who judged as ineligible by clinical investigators
研究者
相似试验
已完成
不适用
A comparative study of renoprotective effect of tolvaptan as an alternative treatment for increasing loop diuretics in patients with chronic kidney disease complicated with chronic heart failurechronic heart failure, chronic kidney diseaseJPRN-UMIN000036119Kawashima hospital40
尚未招募
不适用
Study on Renoprotective effect of cilnidipine and amlodipine along with telmisartan in patients with type-2 diabetes and hypertensioCTRI/2024/04/065259Sri Ramaswamy Memorial
招募中
2 期
Comparison of the renoprotective effects of SGLT2 inhibitor (Empagliflozin) in diabetic and non-diabetic kidney transplantation patientsIRCT20130812014333N168Kermanshah University of Medical Sciences28
进行中（未招募）
1 期
This study will assess the effects of dapagliflozin (a drug that is used in patients with Type 2 Diabetes) on lowering the level of urine protein in patients with non-diabetic kidney disease.Chronic kidney diseaseEUCTR2017-001090-16-NLniversity Medical Center Groningen53
已完成
3 期
A study to assess the renoprotective effects of the SGLT2 inhibitor Dapagliflozin in non-diabetic patients with proteinuria: a randomized double blind 6-week cross-over trialChronic kidney diseaseNL-OMON47662niversitair Medisch Centrum Groningen20